Turnstone Biologics Corp. (Nasdaq:TSBX)
Health Care/Life Sciences • Biotechnology
CIK 1764974
Company
Turnstone Biologics Corp. operates as a clinical stage biotechnology company. It engages in the business of developing and commercializing therapeutics. The company is focused on developing new medicines to treat and cure patients with solid tumors. Turnstone Biologics was founded in 2015 and is headquartered in La Jolla, CA.
Address
9310 Athena Circle
Suite 300
La Jolla, California 92037
9310 Athena Circle
Suite 300
La Jolla, California 92037
Employees
80
80
Stock Info
Close
$0.3709
$0.3709
Day Range
0.3600 - 0.3879
0.3600 - 0.3879
52 Week Range
0.3503 - 4.5400
0.3503 - 4.5400
Average volume
201.6K
201.6K
Short Interest
306.52K (02/14/25)
306.52K (02/14/25)
% of Float Shorted
1.78%
1.78%
Market Cap
$8.4M
$8.4M
Revenue
$19.31M
$19.31M
Net Income
-$55.2M
-$55.2M
2020 Sales Growth
N/A
N/A
Key Executives
Board Of Directors
Chairman Jerel Davis |
President, Chief Executive Officer & Director Sammy J. Farah |
Independent Director Kanya Rajangam |
Independent Director Rishi Gupta |
Independent Director Robert J. Gould |
Director Michael M. Burgess |
Independent Director William D. Waddill |
SEC filings
Date | Form | Event |
---|---|---|
12 Nov, 2024 | 10-Q | |
12 Nov, 2024 | 8-K | |
11 Oct, 2024 | 8-K | |
1 Oct, 2024 | 8-K | |
14 Aug, 2024 | 8-K | |
14 Aug, 2024 | 10-Q | |
2 Jul, 2024 | 4 | |
2 Jul, 2024 | 4 | |
2 Jul, 2024 | 4 | |
2 Jul, 2024 | 4 | |
2 Jul, 2024 | 4 | |
5 Jun, 2024 | 8-K | |
31 May, 2024 | SC 13G/A | |
13 May, 2024 | S-8 | |
13 May, 2024 | 10-Q | |
13 May, 2024 | 8-K | |
29 Apr, 2024 | SC 13G/A | |
22 Apr, 2024 | ARS | |
22 Apr, 2024 | DEFA14A | |
22 Apr, 2024 | DEF 14A | |
16 Apr, 2024 | 3 | |
16 Apr, 2024 | 8-K | |
16 Apr, 2024 | 4 | |
22 Mar, 2024 | 10-K | |
21 Mar, 2024 | 8-K | |
18 Mar, 2024 | SC 13G | |
5 Mar, 2024 | 8-K | |
9 Feb, 2024 | SC 13G/A | |
11 Jan, 2024 | 4 | |
13 Nov, 2023 | 10-Q | |
17 Oct, 2023 | 4 | |
17 Oct, 2023 | 4 | |
17 Oct, 2023 | 4 | |
17 Oct, 2023 | 4 | |
17 Oct, 2023 | 4 | |
17 Oct, 2023 | 4 | |
17 Oct, 2023 | 4 | |
17 Oct, 2023 | 4 | |
17 Oct, 2023 | 4 | |
1 Sep, 2023 | 10-Q | |
3 Aug, 2023 | SC 13D | |
27 Jul, 2023 | 4 | |
27 Jul, 2023 | 4 | |
27 Jul, 2023 | SC 13G | |
27 Jul, 2023 | SC 13G | |
27 Jul, 2023 | 4 | |
25 Jul, 2023 | S-8 | |
25 Jul, 2023 | 8-K | |
24 Jul, 2023 | 424B4 | IPO completed |
24 Jul, 2023 | SC 13D | |
24 Jul, 2023 | 4 | |
24 Jul, 2023 | 4 | |
20 Jul, 2023 | 3 | |
20 Jul, 2023 | 3 | |
20 Jul, 2023 | 3 | |
20 Jul, 2023 | 3 | |
20 Jul, 2023 | 3 | |
20 Jul, 2023 | 3 | |
20 Jul, 2023 | 3 | |
20 Jul, 2023 | CERT | |
20 Jul, 2023 | S-1MEF | |
20 Jul, 2023 | 3 | |
20 Jul, 2023 | 3 | |
20 Jul, 2023 | 3 | |
20 Jul, 2023 | 3 | |
20 Jul, 2023 | EFFECT | |
20 Jul, 2023 | 3 | |
20 Jul, 2023 | 3 | |
20 Jul, 2023 | 3 | |
20 Jul, 2023 | 3 | |
18 Jul, 2023 | CORRESP | |
18 Jul, 2023 | CORRESP | |
17 Jul, 2023 | S-1/A | |
17 Jul, 2023 | 8-A12B | |
5 Jul, 2023 | CORRESP | |
26 Jun, 2023 | S-1/A | |
23 Jun, 2023 | CORRESP | |
22 Jun, 2023 | UPLOAD | |
21 Jun, 2023 | CORRESP | |
12 Jun, 2023 | CORRESP | |
12 Jun, 2023 | UPLOAD | |
12 Jun, 2023 | S-1 | |
15 May, 2023 | DRS | |
14 Jul, 2021 | D |
Last update:2025-03-06 12:24:05.182025
Sign Up to Subscribe
Interested in special situations?
Join Tickerverse
- customize event filters
- create watchlists, bookmarks
- get email notifications for the latest special situations
- browse and analyze public companies, executives and SEC filings
Tickerverse is a great way to find investment opportunities in corporate actions.
By signing up you agree to our Terms of Service and Privacy Policy.